Predictors of Postoperative Left Ventricular Function in Patients Undergoing Mitral Valve Repair for Severe Degenerative Mitral Regurgitation
NCT ID: NCT01519050
Last Updated: 2012-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2011-11-30
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A single center, prospective cohort study
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Degenerative Mitral Regurgitation in Intermediate Risk Patients
NCT02604745
Early Versus Deferred Aortic Valve Replacement in Patients With Moderate Aortic Stenosis and Mitral Regurgitation
NCT05310461
Management and Clinical Outcomes of Patients With Severe Mitral Valve Disease Not Suitable for Surgery
NCT02925819
The Role of Myocardial Fibrosis in Degenerative Mitral Regurgitation
NCT02355418
Cardiopulmonary Exercise Testing in Severe Mitral Regurgitation
NCT03154034
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mitral valve repair
Mitral valve repair in patients with degenerative mitral regurgitation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with severe degenerative mitral regurgitation undergoing mitral valve repair at our institution
Exclusion Criteria
* Presence of relevant (symptomatic) Coronary Artery Disease
* Inability of exercising on semi supine bicycle
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Edwards Lifesciences
INDUSTRY
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patric Biaggi, MD, Senior physican
Role: PRINCIPAL_INVESTIGATOR
University Hospital Zurich, Division of Cardiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich, Division of Cardiology
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KEK ZH 2011- 0274
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.